Jefferies upgraded GE HealthCare (GEHC) to Buy from Hold with a price target of $103, up from $95. The stock has pulled back and now trades at “just” 17-18 times estimated 2025 earnings, below GE HealthCare average, peers, and well off recent highs of 20 times, the analyst tells investors in a research note. The firm says the push out of China stimulus “has helped re-base expects, creating an entry point.” GE is poised to gain share in healthy markets, contends Jefferies.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- 3 Best Stocks to Buy Now, 1/3/2025, According to Top Analysts
- GE HealthCare price target lowered to $98 from $102 at Evercore ISI
- GE HealthCare announces 510(k) submission for CleaRecon DL to FDA
- GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics
- RadNet’s DeepHealth expands FDA clearance for SmartMammo solution